AMAR stock forecast
Our latest prediction for Amarillo Biosciences, Inc.'s stock price was made on the Jan. 13, 2020 when the stock price was at 0.28$.
In the short term (2weeks), AMAR's stock price should outperform the market by 0.13%. During that period the price should oscillate between -11.01% and +21.53%.
In the medium term (3months), AMAR's stock price should underperform the market by -7.62%. During that period the price should oscillate between -44.46% and +60.07%.Get email alerts
About Amarillo Biosciences, Inc.
Amarillo Biosciences, Inc. engages in developing biologics for the treatment of human and animal diseases. It focuses on research aimed at the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon alpha that is administered in a proprietary low dose oral form. The company was founded by Joseph M. Cummins in June 1984 and is headquartered in Amarillo, TX.
At the moment the company doesn't generate any revenue.
On its last earning announcement, the company reported a loss of -0.05$ per share.
The book value per share is 0.02$
Three months stock forecastJan. 13, 2020
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|